Literature DB >> 3700383

Catecholamines induce an increase in nerve growth factor content in the medium of mouse L-M cells.

Y Furukawa, S Furukawa, E Satoyoshi, K Hayashi.   

Abstract

L-M cells, a mouse fibroblast cell line, synthesized and secreted a nerve growth factor (NGF). The neurite outgrowth stimulatory activity, immunoreactivity, molecular weight, and isoelectric point of L-M cell NGF were identical to those of beta-NGF of the mouse submaxillary gland. Treatment of the cells with either norepinephrine or epinephrine in the range of 0.05-0.2 mM for 24 h resulted in a 3-20-fold increase in NGF content in the medium of the L-M cells. The NGF of epinephrine-treated cell was identical to that of control cell. The stimulation of the increase in NGF content was observed after a 4-h lag time. The rate of incorporation of [3H]leucine into trichloroacetic acid-insoluble materials was essentially unchanged during the treatment. These results suggested that norepinephrine and epinephrine stimulated the de novo synthesis and secretion of NGF protein. Evidence is also presented to indicate that the effects of the drugs are due to the catechol part of the molecule and not mediated by adrenergic receptors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3700383

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  Possible Reversal of PTSD-Related DNA Methylation by Sympathetic Blockade.

Authors:  Eugene G Lipov; Kenneth Candido; Elspeth C Ritchie
Journal:  J Mol Neurosci       Date:  2017-03-31       Impact factor: 3.444

2.  Quantitative structure activity relationships of catechol derivatives on nerve growth factor secretion in L-M cells.

Authors:  A Kourounakis; N Bodor
Journal:  Pharm Res       Date:  1995-08       Impact factor: 4.200

Review 3.  Therapy with central active catechol-O-methyltransferase (COMT)-inhibitors: is addition of monoamine oxidase (MAO)-inhibitors necessary to slow progress of neurodegenerative disorders?

Authors:  T Müller; W Kuhn; H Przuntek
Journal:  J Neural Transm Gen Sect       Date:  1993

4.  Catecholamine-containing biodegradable microsphere implants as a novel approach in the treatment of CNS neurodegenerative disease. A review of experimental studies in DA-lesioned rats.

Authors:  A McRae; E A Ling; S Hjorth; A Dahlström; D Mason; T Tice
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

5.  Beneficial effect of diosgenin as a stimulator of NGF on the brain with neuronal damage induced by Aβ-42 accumulation and neurotoxicant injection.

Authors:  Eun-Kyoung Koh; Woo-Bin Yun; Ji-Eun Kim; Sung-Hwa Song; Ji-Eun Sung; Hyun-Ah Lee; Eun-Ji Seo; Seung-Wan Jee; Chang-Joon Bae; Dae-Youn Hwang
Journal:  Lab Anim Res       Date:  2016-06-24

Review 6.  Pleiotropic activity of nerve growth factor in regulating cardiac functions and counteracting pathogenesis.

Authors:  Ewa Pius-Sadowska; Bogusław Machaliński
Journal:  ESC Heart Fail       Date:  2021-01-19

7.  Nerve growth factor transfer from cardiomyocytes to innervating sympathetic neurons activates TrkA receptors at the neuro-cardiac junction.

Authors:  Lolita Dokshokova; Mauro Franzoso; Anna Di Bona; Nicola Moro; Jose Luis Sanchez Alonso; Valentina Prando; Michele Sandre; Cristina Basso; Giuseppe Faggian; Hugues Abriel; Oriano Marin; Julia Gorelik; Tania Zaglia; Marco Mongillo
Journal:  J Physiol       Date:  2022-04-30       Impact factor: 6.228

8.  Cardiac fibroblasts regulate sympathetic nerve sprouting and neurocardiac synapse stability.

Authors:  Céline Mias; Christelle Coatrieux; Colette Denis; Gaël Genet; Marie-Hélène Seguelas; Nathalie Laplace; Charlotte Rouzaud-Laborde; Denis Calise; Angelo Parini; Daniel Cussac; Atul Pathak; Jean-Michel Sénard; Céline Galés
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.